Chardan Capital Reiterates Buy Rating for Tenaya Therapeutics with Raised PT to $8.

jueves, 12 de marzo de 2026, 8:33 am ET1 min de lectura
TNYA--

Chardan Capital Reiterates Buy Rating for Tenaya Therapeutics with Raised PT to $8.

Chardan Capital Reiterates Buy Rating for Tenaya Therapeutics with Raised PT to $8.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios